Why Choose Us?
- Specialization in the synthesis of intricate APIs and their intermediates.
- Avisa Pharma Advanced Research Centre is a Vadodara based R&D stage company, APARC focuses on the development of lab-scale quantities of Cephalosporins, Carbapenems, Anti-inflammatory drugs, Antihypertensive & Cardiovascular APIs.
- Proficiency in synthesizing Cephalosporins, Carbapenems & Cardiovascular.
Product Development Platform
Since its establishment, we are quickly growing towards creating a vast impact on the API industry. We are fast-growing Indian Pharmaceutical company engaged in developing, manufacturing and marketing a broad range of API products.
Avisa Pharma Advanced Research Centre goal is to constantly innovate and deliver affordable and high-quality API to pharmaceutical industry.
Backed by a Robust Leadership and R&D Team
Avisa Pharma’s core leadership team, comprising experienced scientists, collectively possesses over a century of experience in pharmaceutical R&D and API development.
The R&D division comprises a good team of professionals.
State-of-the-Art R&D Infrastructure
Avisa Pharma boasts a well-equipped R&D facility, spanning 6000 sq. ft, for mg-to-kg scale operations, in addition to a 6,000 sq.ft area dedicated to low-volume API production.
The company has established collaborations with GMP contract manufacturing organizations to ensure large-scale commercial supplies.
